Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.030
0.00 (0.00%)
At close: Sep 9, 2026, 4:00 PM EDT
1.040
+0.010 (0.97%)
After-hours: Sep 9, 2026, 7:46 PM EDT
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $11.97 million as of September 9, 2026. Its market cap has decreased by -1.44% in one year.
Market Cap
11.97M
Enterprise Value
-1.03M
1-Year Change
-1.44%
Ranking
Category
Stock Price
$1.03
ChartMarket Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $16.22M to $11.97M, a decrease of -26.23%. That is a compound annual growth rate of -2.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 11.97M | 5.87% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 13.12M |
| Aspire Biopharma Holdings | 12.08M |
| Lunai Bioworks | 11.83M |
| FibroBiologics | 11.72M |
| AEON Biopharma | 11.52M |
| MetaVia | 11.46M |
| Theriva Biologics | 11.43M |
| BioLineRx | 11.25M |